A detailed history of Black Rock Inc. transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 13,455 shares of IMMX stock, worth $24,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,455
Previous 19,321 30.36%
Holding current value
$24,084
Previous $59,000 55.93%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.81 - $3.06 $10,617 - $17,949
-5,866 Reduced 30.36%
13,455 $26,000
Q1 2024

May 10, 2024

BUY
$2.64 - $6.68 $4,247 - $10,748
1,609 Added 9.08%
19,321 $59,000
Q4 2023

Feb 13, 2024

SELL
$2.82 - $7.27 $786 - $2,028
-279 Reduced 1.55%
17,712 $122,000
Q3 2023

Nov 13, 2023

BUY
$1.63 - $3.68 $3,819 - $8,622
2,343 Added 14.97%
17,991 $61,000
Q2 2023

Aug 11, 2023

BUY
$1.6 - $2.9 $25,036 - $45,379
15,648 New
15,648 $42,000
Q2 2022

Aug 12, 2022

SELL
$1.3 - $2.97 $12,239 - $27,962
-9,415 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.86 - $6.75 $17,511 - $63,551
9,415 New
9,415 $22,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $24.9M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.